With an extendable pole fitted with a small camera, Alison Ke could get a clear ...
Hutchmed, a pharmaceutical company, is in the final stages of preparing a submis...
In a surprising turn of events, Gilead Sciences’ hopes for its magrolimab therap...
Novo Holdings, a prominent global life science investor renowned for fostering g...
After a string of failures in the clinic, the Tecentriq/Cabometyx combination de...
The biopharma company has filed a comprehensive patent to address cystic fibrosi...
The gene therapy trials in geographic atrophy and Stargardt disease are planned ...
Hongsik Jake Cho is initiating a project to accelerate progress in stem cell tre...
Qualifyze has secured $12m to improve supply chain compliance in the pharmaceuti...
The US FDA has granted approval for Pfizer’s RSV vaccine, Abrysvo, for use in pr...
Leo Pharma has entered an agreement for the acquisition of US-based clinical-sta...
The company’s generative and predictive AI-powered drug discovery platform is al...
Halia Therapeutics is planning to start two Phase II trials evaluating its lead ...
Janssen’s bispecific antibody received conditional approval as a subcutaneous th...
The functional service provider model can reduce overheads for biopharmaceutical...
One of the hallmarks of Alzheimer’s disease is disruption to the body’s circadia...
